CD4 and common variable immunodeficiency: A risk-benefits ratio of live measles and varicella vaccine administration needs to be considered in those pediatric CVID patients who despite B cell deficiency are capable to preserve their T cell number > 500 cells/mcL CD4 + and > 200 cells/mcL CD8 + cells and function assessed as normal mitogen response [73].